(2E)-3-(2-BUTYL-1-(2-(ETHYLAMINO)ETHYL)-1H-BENZIMIDAZOL-5-YL)-N-HYDROXY-2-PROPENAMIDE
UNII 9H0143U14X
Substance Identification & Data
This profile provides standardized clinical and technical data for (2e)-3-(2-butyl-1-(2-(ethylamino)ethyl)-1h-benzimidazol-5-yl)-n-hydroxy-2-propenamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9H0143U14X.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 929017-34-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C18H26N4O2 ADLOOPCDYMHBCL-CSKARUKUSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (2e)-3-(2-butyl-1-(2-(ethylamino)ethyl)-1h-benzimidazol-5-yl)-n-hydroxy-2-propenamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.